Danny Barash
Senior Academic
Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration
Shortening duration of direct-acting antiviral therapy for chronic hepatitis C could provide cost savings, reduce medication exposure, and foster adherence and treatment completion in special populations. The current analysis indicates that measuring hepatitis C virus at baseline and on days 7 and 14 of therapy can identify patients for shortening therapy duration.
| Publication language | English |
| Journal | Open Forum Infectious Diseases |
| Volume | 9 |
| Issue number | 5 |
| Publication status | Published - 01.05.2022 |
| ofac157 |
Keywords
Direct-acting antivirals
Hepatitis C virus
Mathematical modeling
Response-guided therapy
Time to cure
ASJC Scopus subject areas
Oncology
Infectious Diseases
Sustainable Development Goals
SDG 3 - Good Health and Well-being
